Apersy
Created in 2022
- BETA
To investigate (B)
Some signals may appear as inconsistent with a regular activity Social networks
66Activities
Technologies
Entity types
Location
Nantes, France
Nantes
France
Employees
Scale: 2-10
Estimated: 1
SIREN
947829081Engaged corporates
1
1 0Added in Motherbase
11 months ago
healthtech Value proposition
Expert advisory services for Value, Commercial and Market Access strategy for biotech, digital & medtech
Providing market access insights & strategy for complex & personalised innovative care environments and where the boundaries between device, pharmaceuticals and digital get blurry.
Apersy provide expert advisory services for Market Access, Reimbursement and asset strategy to integrate the commercial point of view throughout the development stages.
Our work supports clients in de-risking reimbursement and market access by providing strategic insights, and shaping products and evidence to meet the requirements of payers and HTA bodies. With global healthcare system expertise, we work in the most innovative areas of healthcare: 🧬 innovative biotech | 📱digital healthcare & AI | 🦠 microbiome medicines
We see that care environments & payer realities for innovative products are changing, so we support rethinking product value to continuously optimise and adapt.
Service pillars:
💡 Product strategy, positioning & due diligence
💡 Market access research & insight, evidence generation planning
💡 Market access training & communication, sense-checks and function support
Biotech, medtech, market access, Pricing and reimbursement, and digital medical devicesOriginal language
Expert advisory services for Value, Commercial and Market Access strategy for biotech, digital & medtech
Providing market access insights & strategy for complex & personalised innovative care environments and where the boundaries between device, pharmaceuticals and digital get blurry.
Apersy provide expert advisory services for Market Access, Reimbursement and asset strategy to integrate the commercial point of view throughout the development stages.
Our work supports clients in de-risking reimbursement and market access by providing strategic insights, and shaping products and evidence to meet the requirements of payers and HTA bodies. With global healthcare system expertise, we work in the most innovative areas of healthcare: 🧬 innovative biotech | 📱digital healthcare & AI | 🦠 microbiome medicines
We see that care environments & payer realities for innovative products are changing, so we support rethinking product value to continuously optimise and adapt.
Service pillars:
💡 Product strategy, positioning & due diligence
💡 Market access research & insight, evidence generation planning
💡 Market access training & communication, sense-checks and function support
Home - |apersy|
Building the foundations of successful reimbursement & market access Disruptive Health Tech & Personalised Medicine Digital Medicines & Healthcare AI Innovative biotech Microbiome products Start shaping product value early Value Creation Value is being created by making appropriate scientific and commercial choices right from the start of the development programme. Know the care environment, healthcare
https://www.apersy.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 7 May 2023 | | |